Pharmaceutical Products Companies By Net Asset

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Net Asset
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Net AssetEfficiencyMarket RiskExp Return
1MLTX MoonLake Immunotherapeutics
477.93 B
(0.19)
 2.81 
(0.53)
2MRNA Moderna
14.14 B
(0.04)
 5.37 
(0.22)
3REVBW Revelation Biosciences
6.62 B
 0.09 
 15.36 
 1.36 
4DRMA Dermata Therapeutics
3.53 B
 0.04 
 4.93 
 0.22 
5AAPG Ascentage Pharma Group
2.5 B
 0.06 
 3.19 
 0.18 
6TLX Telix Pharmaceuticals Limited
1.52 B
 0.10 
 3.22 
 0.32 
7LSBPW LakeShore Biopharma Co,
1.51 B
 0.11 
 23.30 
 2.59 
8DNLI Denali Therapeutics
1.37 B
(0.11)
 4.54 
(0.51)
9MDGL Madrigal Pharmaceuticals
1.04 B
 0.05 
 4.29 
 0.21 
10MRVI Maravai Lifesciences Holdings
1.01 B
(0.21)
 5.63 
(1.21)
11DVAX Dynavax Technologies
986.26 M
 0.07 
 1.51 
 0.10 
12VKTX Viking Therapeutics
908.32 M
(0.13)
 4.80 
(0.63)
13MRUS Merus BV
782.69 M
 0.05 
 2.66 
 0.14 
14MIRM Mirum Pharmaceuticals
670.75 M
 0.08 
 2.52 
 0.20 
15MESO Mesoblast
669.15 M
(0.07)
 4.52 
(0.31)
16VERA Vera Therapeutics
655.68 M
(0.16)
 3.94 
(0.65)
17VERV Verve Therapeutics
647.39 M
(0.01)
 5.55 
(0.07)
18VALN Valneva SE ADR
500.03 M
 0.19 
 5.26 
 0.98 
19ZYBT Zhengye Biotechnology Holding
499.89 M
 0.12 
 8.41 
 0.99 
20UPB Upstream Bio,
481.72 M
(0.25)
 6.10 
(1.52)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund. Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY